Medical Advocates

Elvitegravir
/TenofovirDF/Emtricitabine/Cobicistat
(Stribild)
 
Main Page

New and Noteworthy
Journal Abstracts, Papers, and Commentaries

Conference Reports, Abstracts, and Posters
Cobicistat
FDA Approval



 


ARVs Main Page Main New/Noteworthy Home Page      

Last Update:  August 20, 2017
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy
 

August 2017
 
 

July 2017
 

 

FDA Approval
     

FDA approves new once a day pill for HIV


ARVs Main Page Main New/Noteworthy Home Page      

 Elvitegravir/Tenofovir DF/Emtricitabine/Cobicistat Main Page